LOAN AGREEMENT Dated as of May 8, 2024 among COHERUS BIOSCIENCES, INC. (as Borrower, and a Credit Party), COHERUS INTERMEDIATE CORP. and INTEKRIN THERAPEUTICS INC. (as additional Credit Parties), THE OTHER GUARANTORS SIGNATORY HERETO OR OTHERWISE...Loan Agreement • May 21st, 2024 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances)
THIS LOAN AGREEMENT (this “Agreement”), dated as of May 8, 2024 (the “Closing Date”) by and among COHERUS BIOSCIENCES, INC., a Delaware corporation (as “Borrower” and a Credit Party), COHERUS INTERMEDIATE CORP., a Delaware corporation (as an additional Credit Party), INTEKRIN THERAPEUTICS INC., a Delaware corporation (as an additional Credit Party), Surface Oncology, LLC, a Delaware limited liability company (as an additional Credit Party), Coherus Oncology Supportive Care LLC, a Delaware limited liability company (as an additional Credit Party) and the other Guarantors signatory hereto or otherwise party hereto from time to time, as additional Credit Parties, Ankura Trust Company, LLC, a New Hampshire limited liability company (as the administrative agent and collateral agent, “Collateral Agent”), each of the lenders signatory hereto (each, a “Lender”, and collectively, the “Lenders”), provides the terms on which each Lender shall make, and Borrower shall repay, the Credit Extensions
Revenue Participation Right Purchase and Sale Agreement By and Between Coherus Biosciences, Inc. and Coduet Royalty Holdings, LLC Dated as of May 8, 2024Revenue Participation Right Purchase and Sale Agreement • May 21st, 2024 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
This REVENUE PARTICIPATION RIGHT PURCHASE AND SALE AGREEMENT (this “Agreement”), dated as of May 8, 2024 (the “Effective Date”), is made and entered into by and between Coduet Royalty Holdings, LLC, a Delaware limited liability company, as collateral agent (the “Buyer Representative”) for each buyer set forth on Annex I (each a “Buyer” and collectively, the “Buyer”) and Coherus Biosciences, Inc., a Delaware corporation (the “Seller”).
